Medical Condition News

RSS

Novel imaging approach accurately identifies sub-types of primary aldosteronism

A novel imaging approach, 68Ga-pentixafor PET/CT, has been shown to accurately identify sub-types of primary aldosteronism (an adrenal gland disorder), outperforming traditional methods for diagnosis.

18 Jan 2024

Study explores social and economic factors linked to withdrawal of life support after intracerebral hemorrhage

Living in a high-income neighborhood, having private health insurance, and being older are tied to an increased likelihood that life support will be withdrawn for people who have suffered severe bleeding in the brain, a new study shows.

18 Jan 2024

New blood test technique raises hopes for more sensitive and earlier cancer diagnosis

Tumors constantly shed DNA from dying cells, which briefly circulates in the patient's bloodstream before it is quickly broken down. Many companies have created blood tests that can pick out this tumor DNA, potentially helping doctors diagnose or monitor cancer or choose a treatment.

18 Jan 2024

Remission of diabetes from weight-loss significantly reduces cardiovascular disease risk

While several trials have shown that substantial weight loss using diet and lifestyle can reverse type 2 diabetes, new research published in Diabetologia (the journal of the European Association of the Study of Diabetes [EASD]) is among the first to show the subsequent impact of remission on cardiovascular outcomes.

18 Jan 2024

Plant protein in midlife boosts chances of healthy aging, study finds

A study in The American Journal of Clinical Nutrition reveals that higher dietary protein intake, especially plant protein, in middle adulthood significantly increases the likelihood of healthy aging, reducing chronic diseases and improving physical and mental health.

18 Jan 2024

Wireless magnetogenetic approach could be used to treat motor dysfunction in people with Parkinson’s disease

Electrical deep brain stimulation (DBS) is a well-established method for treating disordered movement in Parkinson's disease.

18 Jan 2024

Machine learning algorithm decodes mutations driving cancer treatment resistance

In a groundbreaking study published on January 18, 2024, in Cancer Discovery, scientists at University of California San Diego School of Medicine leveraged a machine learning algorithm to tackle one of the biggest challenges facing cancer researchers: predicting when cancer will resist chemotherapy.

18 Jan 2024

Uncovering the cellular roots of spinocerebellar ataxia type 6

Researchers from McGill University, led by Professor Alanna Watt of the Department of Biology, have identified previously unknown changes in brain cells affected by a neurological disease.

18 Jan 2024

ARCHA at Aston University secures £400,000 to recruit four PhD students for dementia research

The Aston Research Centre for Health in Ageing (ARCHA) at Aston University has received £400,000 in funding to recruit four PhD students for a dementia research programme.

18 Jan 2024

Cord blood-derived CAR NK cell therapy targeting CD19 shows promise for treating patients with B-cell malignancies

Researchers from The University of Texas MD Anderson Cancer Center reported promising results in a Phase I/II trial of 37 patients with relapsed or refractory B-cell malignancies who were treated with cord blood-derived chimeric antigen receptor (CAR) natural killer (NK) cell therapy targeting CD19.

18 Jan 2024

Morphine shows potential as effective cough therapy for pulmonary fibrosis, study finds

The efficacy of the controlled release of low-dose morphine as treatment against that of a placebo in idiopathic pulmonary fibrosis.

18 Jan 2024

How do SCFAs modulate cardiometabolic risk in normal-weight adults?

How SCFAs modulate cardiometabolic disease risk by interacting with an individual's adiposity parameters and diet.

18 Jan 2024

New targeted therapy eliminates cancer with zero side effects

Johannes Karges develops anti-cancer agents that work in a targeted manner, rather than adversely affecting the entire body.

18 Jan 2024

Short strands of toxic RNAs contribute to brain cell death and DNA damage in Alzheimer's

Alzheimer's disease, which is expected to have affected about 6.7 million patients in the U.S. in 2023, results in a substantial loss of brain cells.

18 Jan 2024

The role of glucose in inducing tolerance to amphotericin B for fungal meningitis treatment

Researchers investigate the mechanism responsible for amphotericin B tolerance of Cryptococcus neoformans.

18 Jan 2024

New bioengineered strategy shows potential for treating ulcerative colitis

By taking advantage of mechanisms that allow cancer cells to evade immune attack, UT Southwestern Medical Center researchers have developed a new strategy in animal models that has potential for treating ulcerative colitis.

17 Jan 2024

OCD patients may have higher risk of death from both natural and unnatural causes

People with obsessive-compulsive disorder (OCD) may have an increased risk of death from both natural and unnatural causes than those without the disorder, finds a study from Sweden published by The BMJ today.

17 Jan 2024

Who's at greater risk for long-COVID? New study sheds light on vulnerable demographics

A study analyzing 134,444 participants from BRFSS and NHIS reveals that 21.5% and 17.1% respectively suffer from long-COVID, with higher risks in middle-aged, female, Hispanic individuals, those with less education, and residents of certain areas.

17 Jan 2024

ALS progression linked to mitochondria-associated membrane-ER disconnection

Researchers at Nagoya University in Japan have discovered a relationship between the progression of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, and the disruption of mitochondria-associated membranes (MAM), the contact point between the mitochondria and the endoplasmic reticulum (ER) of the cell.

17 Jan 2024

23% of dementia cases linked to controllable risk factors vary by race and ethnicity

Approximately 23% of people diagnosed with Alzheimer's disease or another related dementia in their 60s and later have cases that can be explained by controllable risk factors such as high blood pressure, diabetes, physical inactivity, and too little or too much sleep, and that percentage varies depending on race and ethnicity, according to a new study published in the January 17, 2024, online issue of Neurology, the medical journal of the American Academy of Neurology.

17 Jan 2024

Medical Condition News

Novel imaging approach accurately identifies sub-types of primary aldosteronism

Study explores social and economic factors linked to withdrawal of life support after intracerebral hemorrhage

New blood test technique raises hopes for more sensitive and earlier cancer diagnosis

Remission of diabetes from weight-loss significantly reduces cardiovascular disease risk

Plant protein in midlife boosts chances of healthy aging, study finds

Wireless magnetogenetic approach could be used to treat motor dysfunction in people with Parkinson’s disease

Machine learning algorithm decodes mutations driving cancer treatment resistance

Uncovering the cellular roots of spinocerebellar ataxia type 6

ARCHA at Aston University secures £400,000 to recruit four PhD students for dementia research

Cord blood-derived CAR NK cell therapy targeting CD19 shows promise for treating patients with B-cell malignancies

Morphine shows potential as effective cough therapy for pulmonary fibrosis, study finds

How do SCFAs modulate cardiometabolic risk in normal-weight adults?

New targeted therapy eliminates cancer with zero side effects

Short strands of toxic RNAs contribute to brain cell death and DNA damage in Alzheimer's

The role of glucose in inducing tolerance to amphotericin B for fungal meningitis treatment

New bioengineered strategy shows potential for treating ulcerative colitis

OCD patients may have higher risk of death from both natural and unnatural causes

Who's at greater risk for long-COVID? New study sheds light on vulnerable demographics

ALS progression linked to mitochondria-associated membrane-ER disconnection

23% of dementia cases linked to controllable risk factors vary by race and ethnicity

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News